These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4406943

  • 21. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S, Nagaswami R.
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract] [Full Text] [Related]

  • 22. [Principles for amantadine therapy in parkinsonism].
    Gilland O.
    Lakartidningen; 1972 Nov 08; 69(46):5343-5. PubMed ID: 4650743
    [No Abstract] [Full Text] [Related]

  • 23. [Treatment of Parkinson's disease with amantadine].
    Sigwald J, Raymondeaud C, Grégoire J.
    Therapeutique; 1972 Nov 08; 48(9):555-60. PubMed ID: 4568230
    [No Abstract] [Full Text] [Related]

  • 24. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
    Presthus J.
    Tidsskr Nor Laegeforen; 1973 Oct 10; 93(28):2119. PubMed ID: 4773985
    [No Abstract] [Full Text] [Related]

  • 25. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS, England AC.
    Trans Am Neurol Assoc; 1969 Oct 10; 94():85-90. PubMed ID: 4907453
    [No Abstract] [Full Text] [Related]

  • 26. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD, Baxter RC, Marsden CD, Rees JE.
    J Neurol Neurosurg Psychiatry; 1974 Apr 10; 37(4):422-6. PubMed ID: 4838913
    [Abstract] [Full Text] [Related]

  • 27. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS, Bauer RB, Rosenbaum H.
    Geriatrics; 1971 Aug 10; 26(8):61-70. PubMed ID: 5096462
    [No Abstract] [Full Text] [Related]

  • 28. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD, Zilkha KJ, Knill-Jones RP, Clements PJ, Baxter R.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr 10; 4(3):356-60. PubMed ID: 4931417
    [No Abstract] [Full Text] [Related]

  • 29. Mental symptoms in parkinsonian patients treated with L-dopa.
    Herson RN.
    Lancet; 1970 Oct 03; 2(7675):721. PubMed ID: 4195955
    [No Abstract] [Full Text] [Related]

  • 30. L-dopa level in plasma, primary condition for the kinetic effect.
    Birkmayer W, Danielcyk W, Neumayer E, Riederer P.
    J Neural Transm; 1973 Oct 03; 34(2):133-43. PubMed ID: 4722571
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T.
    No To Shinkei; 1970 Dec 03; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract] [Full Text] [Related]

  • 32. L-dopa in the treatment of Parkinsonism; a preliminary appraisal.
    Stellar S, Mandell S, Waltz JM, Cooper IS.
    J Neurosurg; 1970 Mar 03; 32(3):275-80. PubMed ID: 5416909
    [No Abstract] [Full Text] [Related]

  • 33. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J, Raymondeaud C, Piot C.
    Rev Neurol (Paris); 1970 Feb 03; 122(2):145-8. PubMed ID: 4931718
    [No Abstract] [Full Text] [Related]

  • 34. The treatment of parkinsonism with L-Dopa and amantadine.
    Green J.
    J Fla Med Assoc; 1970 Jun 03; 57(6):28-33. PubMed ID: 5445813
    [No Abstract] [Full Text] [Related]

  • 35. Amantadine in Parkinson's disease. Review of more than two years' experience.
    Schwab RS, Poskanzer DC, England AC, Young RR.
    JAMA; 1972 Nov 13; 222(7):792-5. PubMed ID: 4677928
    [No Abstract] [Full Text] [Related]

  • 36. [Advances in the treatment of parkinsonism].
    Dowzenko A.
    Neurol Neurochir Pol; 1972 Nov 13; 6(2):275-80. PubMed ID: 4555308
    [No Abstract] [Full Text] [Related]

  • 37. [Therapy of parkinsonism using L-dopa. I].
    Glass J.
    Z Arztl Fortbild (Jena); 1972 Dec 01; 66(23):1195-9. PubMed ID: 4652156
    [No Abstract] [Full Text] [Related]

  • 38. The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome.
    Fehling C.
    Acta Neurol Scand; 1973 Dec 01; 49(2):245-51. PubMed ID: 4577929
    [No Abstract] [Full Text] [Related]

  • 39. Amantadine and L-dopa.
    Andrews CJ.
    Aust N Z J Med; 1972 Aug 01; 2(3):292-3. PubMed ID: 4508250
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.